Exogenous nitric oxide generated from SNAP blocks porcine circovirus type 2 replication and regulates NF-κB activity in PK-15 cells

Chuanmin Liu,Zhisheng Wang,Qiannan Zhang,Bo Zhang,Tao Xue,Jinping Fu
DOI: https://doi.org/10.1016/j.ijantimicag.2023.106859
IF: 15.441
2023-05-27
International Journal of Antimicrobial Agents
Abstract:PCV2-associated disease (PCVAD), caused by porcine circovirus type 2 (PCV2) infection, is one of the major infectious diseases in the global swine industry. Nitric oxide (NO), as an important signaling molecule, has antiviral activities against a variety of viruses. To date, limited knowledge is available on the role of NO during PCV2 infection. This study was conducted to investigate the effects of exogenous NO on PCV2 replication in vitro . Kinetics of NO production indicated that S-nitroso- acetylpenicillamine (SNAP) produced NO in a dose-dependent manner, while NO was scavenged by its scavenger hemoglobin (Hb). An in vitro antiviral assay demonstrated that exogenous NO strongly inhibited PCV2 replication in a time- and dose-dependent manner, whereas the inhibitory effects could be reversed by Hb. Furthermore, inhibition of NF-κB activity induced by NO contributed to a notable decrease in PCV2 replication. Our findings provide a new potential antiviral therapy against PCV2 infection, and the antiviral effects of exogenous NO may be partly achieved by regulating NF-κB activity.
pharmacology & pharmacy,infectious diseases,microbiology
What problem does this paper attempt to address?